Review Article
Gastric Collision Tumors: An Insight into Their Origin and Clinical Significance
Table 1
Neuroendocrine carcinoma and gastric adenocarcinoma collision tumors.
| Author | Sex/age | Gastric adenocarcinoma | Nodes | Follow-up | Adjuvant treatment |
| Grossi and Lattes [39], 1956 | M/74 | N/A | N/A | 12 m | N/A | Parks [20], 1970 | M/54 | N/A | NEC/GA (+) | 3 m (DOD) | N/A | Yamashina and Flinner [40], 1985 | M/50 | Mixed | NEC (+) | N/A | N/A | Yoshino et al. [37], 1987 | F/63 | WD | N/A | N/A | N/A |
Chodankar et al. [41], 1989 | F/69 | WD | — | N/A | N/A | Morishita et al. [28], 1991 | M/49 | MD | N/A | N/A | N/A | Corsi and Bosman [42], 1995 | M/72 | MD | N/A | N/A | N/A | Fukui et al. [21], 2001 | M/63 | PD | N/A | N/A | N/A |
de Leval et al. [11], 2002 | M/87 | WD | NEC (+) | 1 m (DOD) | N/A | Olinici et al. [43], 2004 | M/68 | N/A | N/A | N/A | N/A | Morishita et al. [44], 2005 | F/84 | MD | GA (+) | 33 m | N/A |
Jayaraman et al. [45], 2005 | M/48 | MD | N/A | N/A | N/A | Jang et al. [10], 2010 | M/50 | WD | NEC (+) | N/A | N/A | Doggui et al. [12], 2008 | M/55 | N/A | N/A | 3 m (DOD) | Chemo | Mardi et al. [46], 2008 | F/47 | WD | GA (+) | N/A | N/A |
Mróz et al. [8], 2009 | M/56 | PD | GA (+) | N/A | N/A | Lee et al. [33], 2011 | M/62 | PD | — | N/A | N/A |
Ünal et al. [35], 2013 | F/51 | MD | GA (+) | 5 m (DOD) | N/A |
|
|
N/A: Not available. WD: Well differentiated. MD: Moderately differentiated. PD: Poorly differentiated. NEC: Neuroendocrine carcinoma. GA: Gastric adenocarcinoma. m: Months. DOD: Dead of disease.
|